H. Tsutsui et al.
Bull. Chem. Soc. Jpn., 75, No. 7 (2002) 1457
= 14.0, 8.9 Hz), 2.32–2.39 (1H, m), 2.73 (1H, dt, J = 16.7, 4.0
Hz), 2.91–3.00 (1H, m), 3.55–3.61 (1H, m), 5.01–5.08 (2H, m),
5.71–5.81 (1H, m), 7.18 (1H, d, J = 7.6 Hz), 7.23 (1H, t, J = 7.6
Hz), 7.36 (1H, t, J = 7.6 Hz), 8.14 (1H, d, J = 7.6 Hz); 13C NMR
(125 MHz, CDCl3) δ 24.20, 24.34, 33.57, 33.73, 106.72–107.24
(m), 117.37, 126.21, 126.56, 127.36, 129.01, 131.29, 134.96,
136.52–136.97 and 138.54–138.96 (m d), 139.95, 142.15–142.54,
144.18–144.61, and 146.22–146.69 (overlapped, m), 156.51,
166.22; Anal. Found: C, 60.46; H, 3.49; N, 3.34%. Calcd for
C20H14F5NO2: C, 60.76; H, 3.57; N, 3.54%.
1-Phenyl-4-penten-1-one (E)-O-Pentafluorobenzoyloxime
(E-9c): Colorless crystals; mp 82–84 °C; IR (KBr) 1755, 1655,
1524, 1501, 1418, 1330, 1198, 1002, 922, 890, 773, 696 cm−1; 1H
NMR (500 MHz, CDCl3) δ 2.28–2.36 (2H, m), 2.98 (2H, t, J =
7.8 Hz), 4.98–5.05 (2H, m), 5.73–5.83 (1H, m), 7.42 (2H, t, J =
7.2 Hz), 7.48 (1H, t, J = 7.2 Hz), 7.72 (2H, d, J = 7.2 Hz); 13C
NMR (125 MHz, CDCl3) δ 28.13, 30.62, 107.01–107.15 (m),
116.01, 127.39, 128.74, 131.03, 132.97, 136.01, 136.55–136.97
and 138.54–138.98 (m d), 142.18–142.66, 144.26–144.69, and
146.31–146.68 (overlapped, m), 156.45, 168.10; Anal. Found: C,
58.48; H, 3.32; N, 3.85%. Calcd for C18H12F5NO2: C, 58.54; H,
3.28; N, 3.79%.
1-Phenyl-4-penten-1-one (Z)-O-Pentafluorobenzoyloxime
(Z-9c): Colorless oil; IR (KBr) 1767, 1652, 1505, 1423, 1327,
1197, 1083, 1005, 922, 871, 767, 700 cm−1; 1H NMR (500 MHz,
CDCl3) δ 2.23–2.30 (2H, m), 2.83 (2H, t, J = 7.6 Hz), 4.98–5.05
(2H, m), 5.74–5.84 (1H, m), 7.27–7.31 (2H, m), 7.39–7.43 (3H,
m); 13C NMR (125 MHz, CDCl3) δ 30.02, 34.84, 106.71–107.01
(m), 115.84, 126.86, 128.22, 129.69, 132.12, 136.00, 136.22–
136.68 and 138.27–138.65 (m d), 141.89–142.28, 143.87–144.34,
and 145.96–146.30 (overlapped, m), 156.48, 168.95; FABHRMS
Found: m/z 370.0876. Calcd for C18H13F5NO2: M + H, 370.0867.
146.58–146.86 (overlapped, m), 155.48, 161.47, 162.19; Anal.
Found: C, 49.20; H, 3.24; N, 3.74%. Calcd for C15H12F5NO4: C,
49.32; H, 3.31; N, 3.83%.
1-Ethyl 7-Methyl (E)-6-[(E)-Pentafluorobenzoyloxyimino]-
2-heptenedioate (E-9g): Colorless plates; mp 75–76 °C (hex-
ane); IR (KBr) 1789, 1728, 1652, 1501, 1446, 1326, 1253, 1178,
1126, 1078, 1002, 951, 901, 849, 766 cm−1; 1H NMR (300 MHz,
CDCl3) δ 1.25 (3H, t, J = 7.2 Hz), 2.42–2.53 (2H, m), 3.91 (3H,
s), 4.14 (2H, q, J = 7.2 Hz), 5.82 (1H, dt, J = 15.6, 1.4 Hz), 6.86
(1H, dt, J = 15.6, 7.0 Hz); 13C NMR (75 MHz, CDCl3) δ 13.70,
25.84, 28.16, 53.10, 59.94, 105.08–105.67 (m), 122.56, 135.61–
136.22 and 138.94–139.62 (m d), 141.70–142.41 and 145.11–
145.78 (m d), 143.59–144.14 and 146.93–147.53 (m d), 144.86,
154.94, 159.83, 162.25, 165.52; Anal. Found: C, 48.32; H, 3.32;
N, 3.09%. Calcd for C17H14F5NO6: C, 48.24; H, 3.33; N, 3.31%.
Ethyl
(E)-6-(Pentafluorobenzoyloxyimino)-8-phenyl-2-
octenoate (9h): E:Z = 3:1 mixture; White solid; mp 41–55 °C;
IR (KBr) 1757, 1714, 1651, 1494, 1453, 1416, 1368, 1326, 1254,
1190, 1090, 1033, 1000, 942, 865, 772, 716 cm−1; 1H NMR (500
MHz, CDCl3) E-isomer: δ 1.26 (3H, t, J = 7.1 Hz), 2.37–2.44
(2H, m), 2.57 (2H, t, J = 7.4 Hz), 2.67–2.74 (2H, m), 2.94 (2H, t,
J = 7.7 Hz), 4.16 (2H, q, J = 7.1 Hz), 5.80 (1H, dt, J = 15.6, 1.4
Hz), 6.85 (1H, dt, J = 15.6, 6.9 Hz), 7.17–7.23 (3H, m), 7.24–
7.31 (2H, m); Z-isomer: δ 1.27 (3H, t, J = 7.1 Hz), 2.37–2.44 (2H,
m), 2.45–2.52 (2H, m), 2.67–2.74 (2H, m), 2.85 (2H, t, J = 7.7
Hz), 4.17 (2H, q, J = 7.1 Hz), 5.81 (1H, dt, J = 15.7, 1.5 Hz),
6.88 (1H, dt, J = 15.7, 6.4 Hz), 7.13 (2H, d, J = 7.6 Hz), 7.17–
7.23 (1H, m), 7.24–7.31 (2H, m); 13C NMR (125 MHz, CDCl3) E-
isomer: δ 13.77, 27.88, 28.44, 31.73, 35.72, 60.00, 106.48–106.70
(m), 122.37, 126.05, 127.96, 128.22, 136.23–136.65 and 138.23–
138.67 (m d), 139.90, 141.86–142.31, 143.90–144.24, and
145.96–146.35 (overlapped, m), 145.36, 156.00, 165.63, 169.49;
Z-isomer: δ 13.81, 27.63, 31.63, 31.96, 32.79, 59.93, 106.48–
106.70 (m), 122.15, 126.25, 127.83, 128.27, 136.23–136.65 and
138.23-138.67 (m d), 139.43, 141.86–142.31, 143.90–144.24, and
145.96–146.35 (overlapped, m), 146.04, 156.00, 165.83, 169.49;
1,8-Nonadien-5-one
O-Pentafluorobenzoyloxime
(9d):
White solid; mp < 30 °C; IR (KBr) 1766, 1652, 1525, 1505,
1
1419, 1327, 1202, 1093, 1004, 919, 867 cm−1; H NMR (500
MHz, CDCl3) δ 2.25–2.32 (2H, m), 2.33–2.40 (2H, m), 2.46–2.54
(4H, m), 4.99–5.11 (4H, m), 5.71–5.87 (2H, m); 13C NMR (125
MHz, CDCl3) δ 29.08, 29.70, 29.83, 33.36, 106.83–107.24 (m),
115.63, 115.87, 135.94, 136.29, 136.38–136.77 and 138.37–
138.89 (m d), 141.86–142.39, 144.02–144.41, and 146.10–146.41
(overlapped, m), 156.35, 170.72; Anal. Found: C, 55.21; H, 4.00;
N, 4.01%. Calcd for C16H14F5NO2: C, 55.34; H, 4.06; N, 4.03%.
3-Methyl-1-phenyl-4-penten-1-one (E)-O-Pentafluoroben-
zoyloxime (E-9e): White powder; mp 69–73 °C; IR (KBr)
1755, 1652, 1526, 1498, 1417, 1328, 1203, 1004, 950, 924, 874,
Anal. Found: C, 58.85; H, 4.37; N, 2.96%.
C23H20F5NO4: C, 58.85; H, 4.29; N, 2.98%.
Calcd for
Ethyl (E)-6-[(E)-Pentafluorobenzoyloxyimino]-6-phenyl-2-
hexenoate (E-9i): Colorless crystals; mp 93–95 °C; IR (KBr)
1760, 1716, 1652, 1528, 1494, 1324, 1284, 1196, 895, 769, 697
1
cm−1; H NMR (500 MHz, CDCl3) δ 1.25 (3H, t, J = 7.2 Hz),
2.42–2.50 (2H, m), 3.04 (2H, t, J = 7.7 Hz), 4.15 (2H, q, J = 7.2
Hz), 5.81 (1H, dt, J = 15.6, 1.4 Hz), 6.89 (1H, dt, J = 15.6, 6.9
Hz), 7.43 (2H, dt, J = 1.5, 7.2 Hz), 7.49 (1H, dt, J = 1.5, 7.2 Hz),
7.71 (2H, dd, J = 1.5, 7.2 Hz); 13C NMR (125 MHz, CDCl3) δ
14.03, 27.09, 28.92, 60.25, 106.52–106.83 (m), 122.58, 127.28,
128.83, 131.22, 132.49, 136.55–136.93 and 138.56–138.93 (m d),
142.25–142.66, 144.27–144.70, and 146.31–146.68 (overlapped,
m), 145.51, 156.18, 165.93, 167.05; Anal. Found: C, 57.02; H,
3.63; N, 2.95%. Calcd for C21H16F5NO4: C, 57.15; H, 3.65; N,
3.17%.
1
744, 695 cm−1; H NMR (300 MHz, CDCl3) δ 1.02 (3H, d, J =
6.8 Hz), 2.37–2.52 (1H, m), 2.84–2.99 (2H, m), 4.85–4.95 (2H,
m), 5.59–5.73 (1H, m), 7.35–7.52 (3H, m), 7.69 (2H, dd, J = 1.8,
7.7 Hz); 13C NMR (75 MHz, CDCl3) δ 19.77, 35.12, 35.96,
106.74–107.39 (m), 113.87, 127.54, 128.70, 130.90, 133.32,
135.75–136.38 and 139.14–139.70 (m d), 141.41–142.10 and
144.78–145.52 (m d), 141.78, 143.47–143.94 and 146.85–147.46
(m d), 156.47, 167.76; Anal. Found: C, 59.35; H, 3.65; N, 3.68%.
Calcd for C19H14F5NO2: C, 59.53; H, 3.68; N, 3.65%.
1-Phenyl-4-hexen-1-one
(E)-O-Pentafluorobenzoyloxime
(E-9j): E:Z = 2:1 mixture; White solid; mp 59–70 °C; IR
Ethyl 2-[(E)-Pentafluorobenzoyloxyimino]-5-hexenoate (E-
9f): Colorless oil; IR (KBr) 1779, 1732, 1652, 1505, 1418,
(KBr) 1754, 1653, 1607, 1525, 1498, 1466, 1444, 1324, 1200,
1
1097, 1040, 1002, 971, 951, 888, 774, 745, 695, 627 cm−1; H
1
1375, 1326, 1185, 1078, 1006, 901, 767 cm−1; H NMR (500
NMR (500 MHz, CDCl3) δ 1.48 (1H, dd, J = 0.9, 6.8 Hz), 1.60
(2H, dd, J = 1.0, 6.0 Hz), 2.20–2.27 (1.33H, m), 2.28–2.36
(0.67H, m), 2.88–2.96 (2H, m), 5.31–5.52 (2H, m), 7.36–7.50
(3H, m), 7.67–7.76 (2H, m); 13C NMR (125 MHz, CDCl3) δ
12.45, 17.65, 24.05, 28.45, 28.85, 29.59, 106.82–107.51 (m, over-
lapped), 125.65, 126.81, 127.40 (overlapped), 127.60, 128.60,
MHz, CDCl3) δ 1.37 (3H, t, J = 7.2 Hz), 2.29–2.36 (2H, m), 2.81
(2H, t, J = 7.6 Hz), 4.36 (2H, q, J = 7.2 Hz), 4.98–5.08 (2H, m),
5.70–5.80 (1H, m); 13C NMR (125 MHz, CDCl3) δ 13.83, 27.00,
30.05, 62.78, 105.73–106.12 (m), 116.38, 135.52, 136.55–136.97
and 138.57–138.97 (m d), 142.59–142.96, 144.43–145.07, and